Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

By Rossi Carlo  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3000-3007

Springer Publishing Company

Access to resources Recommend Favorite

Isolated limb perfusion for malignant melanoma; possibly better results with high dose hyperthermia

By  

International Journal of Hyperthermia, Vol. 24, Iss. 7, 2008-01 ,pp. : 602-603

Informa Healthcare

Access to resources Recommend Favorite

Correlation Between Melphalan Pharmacokinetics and Hepatic Toxicity Following Hyperthermic Isolated Liver Perfusion for Unresectable Metastatic Disease

By Mocellin Simone   Pilati Pierluigi   Pian Pierpaolo   Forlin Marco   Corazzina Susanna   Rossi Carlo   Innocente Federico   Ori Carlo   Casara Dario   Ujka Francesca   Nitti Donato   Lise Mario  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 802-809

Springer Publishing Company

Access to resources Recommend Favorite

Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma

By Hayes Andrew   Neuhaus Susan   Clark Matthew   Thomas J.  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 230-238

Springer Publishing Company

Access to resources Recommend Favorite

Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon's perspective

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-01 ,pp. : 898-902

Spandidos Publications

Access to resources Recommend Favorite